Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flomoxef vs Cefepime in cUTI
NCT02302092Phase 3Terminated
- Sponsor
- Takeda
- Start
- Dec 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of flomoxef in complicated urinary tract infection (cUTI), pyelonephritis, sponsored by Takeda. Started Dec 2015; status: terminated.
02
Drugs
flomoxef
03
Conditions
complicated urinary tract infection (cUTI)pyelonephritis
Beyond the preview
Go deeper on NCT02302092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02302092.